[Treatment of polycystic ovarian syndrome with anovulatory infertility by ultrasound-guided immature follicle aspiration].

What Was Tested

Researchers studied Chorionic Gonadotropin in this randomized controlled trial publication.

To investigate the effect of ultrasound-guided immature follicle aspiration (IMFA) on polycystic ovarian syndrome (PCOS) in women with anovulatory infertility, such as the endocrinology of the patients and the basic follicles number in the ovaries, and to observe the ovarian response to human menopausal gonadotropin (hMG) stimulation and pregnancy after the therapy.

Who Took Part

The abstract describes 34 patients taking part.

PubMed indexes the participants as adults, women only.

Seventy-one PCOS patients were involved in this trial, and divided into 2 groups.

Thirty-seven patients of group I were primed with slight amount of hMG, the other 34 patients did not use hMG.

How the Study Was Run

In design terms this was a randomized study.

Random assignment meant chance, not the researchers, decided who got Chorionic Gonadotropin and who got the comparison, which limits bias.

Ultrasound-guided IMFA was performed 36 hour after human chorionic gonadotropin (hCG) administration.

In the next cycle, the basal endocrinology and the basic number of follicles were checked, then IMFA were performed continuously until the basic number of follicles were under 10 per ovary.

Afterwards, hMG were used to stimulate ovulation and the pregnant results were followed up.

What Was Measured

PubMed files the paper under topics including Chorionic Gonadotropin, Infertility, Female, Oocyte Retrieval, Ovarian Follicle, Polycystic Ovary Syndrome and Ultrasonography.

What This Means in Plain Language

The paper is a randomized study of Chorionic Gonadotropin in 34 patients.

With fewer than 40 people, it is a small study, so it is better read as an early signal for further research than as a settled answer.

Its findings take up roughly 7 sentences of the abstract and are left out here on purpose; the source paper is the place to read them.

The publication is from 2005 (Zhonghua fu chan ke za zhi), a journal based in China.

More context: the related hCG (human chorionic gonadotropin) library page, all human trials.